Q1 2021 Holdings
Filed 2021-05-17 | 120 holdings | $829.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $395.9M | 6,411,355 | 47.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $133.6M | 2,168,909 | 16.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $92.1M | 2,490,065 | 11.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $65.0M | 881,770 | 7.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $50.4M | 2,000,000 | 6.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $21.1M | 1,904,424 | 2.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $13.7M | 171,775 | 1.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $12.9M | 100,000 | 1.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $11.3M | 200,000 | 1.4% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $10.9M | 100,000 | 1.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $8.3M | 30,000 | 1.0% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $6.3M | 150,000 | 0.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.4M | 422,167 | 0.3% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $1.4M | 150,000 | 0.2% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $441.9K | 2,000,000 | 0.1% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $396.3K | 1,000,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $260.1K | 2,750,000 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $146.4K | 5,114,850 | 0.0% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $135.7K | 1,000,000 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $132.3K | 4,720,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $115.8K | 2,525,000 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $109.9K | 2,192,060 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $105.1K | 3,195,544 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $80.1K | 1,866,108 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $74.3K | 2,340,914 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $63.2K | 2,000,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $60.7K | 1,368,550 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $58.7K | 3,300,030 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $55.8K | 1,437,807 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $55.3K | 1,714,269 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $53.8K | 2,464,545 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $47.1K | 275,000 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $45.3K | 250,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $43.6K | 850,000 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $41.5K | 693,000 | 0.0% |
| Dermtech Inc(DMTKQ) | COM | 24984K105 | $40.6K | 800,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $39.9K | 400,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $38.0K | 495,769 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $37.3K | 275,000 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $37.2K | 1,230,000 | 0.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $37.2K | 2,356,000 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $36.6K | 2,098,024 | 0.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $35.2K | 1,074,145 | 0.0% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $32.3K | 3,000,000 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $28.8K | 1,267,167 | 0.0% |
| 908 Devices Inc(MASS) | COM | 65443P102 | $25.9K | 545,322 | 0.0% |
| Intellia Therapeutics Inc(NTLA)Put | COM | 45826J105 | $24.1K | 300,000 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $24.0K | 611,409 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $24.0K | 247,200 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $23.9K | 4,000,000 | 0.0% |